First-line Olaparib Combined With Bevacizumab Maintenance Therapy
NCT05440578
·
clinicaltrials.gov ↗
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Ovarian Neoplasms
Interventions
DRUG:
olaparib plus bevacizumab maintenance therapy
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University